Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Radium-224"'
Publikováno v:
EJNMMI Radiopharmacy and Chemistry, Vol 8, Iss 1, Pp 1-27 (2023)
Abstract Background The alpha-emitter radium-223 (223Ra) is presently used in nuclear medicine for the palliative treatment of bone metastases from castration-resistant prostate cancer. This application arises from its advantageous decay properties a
Externí odkaz:
https://doaj.org/article/b8a92ffbe0d0467f8c801e2fa88dbcc7
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/7831ea8b0c244da9b2930733232398ab
Autor:
Simen Rykkje Grønningsæter, Johan Blakkisrud, Silje Selboe, Mona-Elisabeth Revheim, Øyvind Sverre Bruland, Tina Bjørnlund Bønsdorff, Stein Gunnar Larsen, Caroline Stokke
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
AimTwo ongoing phase I studies are investigating the use of radium-224 adsorbed to calcium carbonate micro particles (224Ra-CaCO3-MP) to treat peritoneal metastasis originating from colorectal or ovarian cancer. The aim of this work was to study the
Externí odkaz:
https://doaj.org/article/b0d173692f8d4056b9aa21a0313d575f
Autor:
Asta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland, Mona-Elisabeth Revheim, Roy Hartvig Larsen
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
Metastases are the primary cause of death among cancer patients and efficacious new treatments are sorely needed. Targeted alpha-emitting radiopharmaceuticals that are highly cytotoxic may fulfill this critical need. The focus of this paper is to des
Externí odkaz:
https://doaj.org/article/d7c8d3316aea442f97f2e4ac8628bf55
Autor:
Anna Julie Kjøl Tornes, Vilde Yuli Stenberg, Roy Hartvig Larsen, Øyvind Sverre Bruland, Mona-Elisabeth Revheim, Asta Juzeniene
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Osteosarcoma patients with overt metastases at primary diagnosis have a 5-year survival rate of less than 20%. TP-3 is a murine IgG2b monoclonal antibody with high affinity for an epitope residing on the p80 osteosarcoma cell surface membrane antigen
Externí odkaz:
https://doaj.org/article/08e58ac533f34f7f8cbefaa9a9134bae
Autor:
Roxanne Wouters, Sara Westrøm, Yani Berckmans, Matteo Riva, Jolien Ceusters, Tina B. Bønsdorff, Ignace Vergote, An Coosemans
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
A novel alpha-therapy consisting of 224Ra-labeled calcium carbonate microparticles (224Ra-CaCO3-MP) has been designed to treat micrometastatic peritoneal disease via intraperitoneal (IP) administration. This preclinical study aimed to evaluate its ef
Externí odkaz:
https://doaj.org/article/293bce168e4649ebab737b967704a0ad
Autor:
Mondor, Julien
La curiethérapie par diffusion d’émetteurs alpha (DaRT) est un nouveau type de grain interstitiel dont le potentiel thérapeutique pour les tumeurs solides est élevé en raison de l’utilisation de particules alpha. Cette modalité se distingue
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Roxanne Wouters, Sara Westrøm, Yani Berckmans, Matteo Riva, Jolien Ceusters, Tina B. Bønsdorff, Ignace Vergote, An Coosemans
A novel alpha-therapy consisting of 224Ra-labeled calcium carbonate microparticles (224Ra-CaCO3-MP) has been designed to treat micrometastatic peritoneal disease via intraperitoneal (IP) administration. This preclinical study aimed to evaluate its ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f29ef06deeea842a542481ea4bd02c3
https://lirias.kuleuven.be/handle/20.500.12942/705415
https://lirias.kuleuven.be/handle/20.500.12942/705415